Steven Lo Insider Trading $PBYI PUMA BIOTECHNOLOGY, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Steven Lo.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Steven Lo. Steven Lo is SVP Oncology in CORCEPT THERAPEUTICS INC ($CORT) and VP Commercial Operations in CORCEPT THERAPEUTICS INC ($CORT) and Chief Commercial Officer in PUMA BIOTECHNOLOGY, INC. ($PBYI) and Chief Executive Officer in Zosano Pharma Corp ($ZSAN).
Steven Lo in PUMA BIOTECHNOLOGY, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Steven Lo: Chief Commercial Officer
Holdings: 19,557 shares
Current Value: $662,004
Latest Transaction: Jul 24 2019
$PBYI Market Capitalization: $1.37B
$PBYI Previous Close: $33.85
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Steven Lo in PUMA BIOTECHNOLOGY, INC.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, CORT, PBYI, ZSAN
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 24 2019 | PBYI | PUMA BIOTECHNOLOGY ... | Lo Steven | Chief Commercial Of ... | Sell | S | 10.04 | 1,852 | 18,600 | 19,557 | 21.4 K to 19.6 K (-8.65 %) |
| Feb 08 2019 | PBYI | PUMA BIOTECHNOLOGY ... | Lo Steven | Chief Commercial Of ... | Option Exercise | A | 27.76 | 36,300 | 1,007,688 | 36,300 | |
| Jan 24 2019 | PBYI | PUMA BIOTECHNOLOGY ... | Lo Steven | Chief Commercial Of ... | Sell | S | 24.91 | 2,114 | 52,664 | 21,409 | 23.5 K to 21.4 K (-8.99 %) |
| Jul 24 2018 | PBYI | PUMA BIOTECHNOLOGY ... | Lo Steven | Chief Commercial Of ... | Sell | S | 51.85 | 1,839 | 95,360 | 23,523 | 25.4 K to 23.5 K (-7.25 %) |
| Feb 13 2018 | PBYI | PUMA BIOTECHNOLOGY ... | Lo Steven | Chief Commercial Of ... | Option Exercise | A | 60.85 | 33,000 | 2,008,050 | 33,000 | |
| Jan 24 2018 | PBYI | PUMA BIOTECHNOLOGY ... | Lo Steven | Chief Commercial Of ... | Sell | S | 92.85 | 1,858 | 172,515 | 25,362 | 27.2 K to 25.4 K (-6.83 %) |
| Jul 24 2017 | PBYI | PUMA BIOTECHNOLOGY ... | Lo Steven | Chief Commercial Of ... | Sell | S | 94.90 | 1,990 | 188,853 | 27,220 | 29.2 K to 27.2 K (-6.81 %) |
| Feb 21 2017 | PBYI | PUMA BIOTECHNOLOGY ... | Lo Steven | Chief Commercial Of ... | Option Exercise | A | 37.35 | 31,500 | 1,176,525 | 31,500 | |
| Jan 24 2017 | PBYI | PUMA BIOTECHNOLOGY ... | Lo Steven | Chief Commercial Of ... | Sell | S | 33.24 | 2,290 | 76,108 | 29,210 | 31.5 K to 29.2 K (-7.27 %) |
| Oct 14 2016 | PBYI | PUMA BIOTECHNOLOGY ... | Lo Steven | Chief Commercial Of ... | Grant | A | 0.00 | 31,500 | 0 | 31,500 | 0 to 31.5 K |
| May 27 2016 | PBYI | PUMA BIOTECHNOLOGY ... | Lo Steven | Chief Commercial Of ... | Option Exercise | A | 35.61 | 30,000 | 1,068,300 | 30,000 | |
| Sep 10 2015 | PBYI | PUMA BIOTECHNOLOGY ... | Lo Steven | Chief Commercial Of ... | Option Exercise | A | 95.22 | 150,000 | 14,283,000 | 150,000 |
Page: 1